Oral corticosteroid therapy and present disease status in myasthenia gravis.

Abstract

INTRODUCTION:

The aim of this study was to elucidate the effectiveness of oral prednisolone (PSL) according to dosing regimen in 472 patients with myasthenia gravis (MG).

METHODS:

We compared the clinical characteristics and PSL treatment between 226 patients who achieved minimal manifestations (MM) or better and 246 patients who remained improved (I) or worsened, according to the MG Foundation of America postintervention status.

RESULTS:

Achievement of MM or better at peak PSL dose (odds ratio 12.25, P < 0.0001) and combined use of plasma exchange/plasmapheresis (PE/PP) and/or intravenous immunoglobulin (IVIg) (odds ratio 1.92, P = 0.04) were associated positively, and total PSL dose during the past year (odds ratio 0.17, P = 0.03) was associated negatively with present MM or better status.

CONCLUSIONS:

Higher PSL dose and longer PSL treatment do not ensure better outcome. In the absence of a good response, the PSL dose should be decreased by combining with modalities such as PE/PP or IVIg.

• Authors: Tomihiro Imai, Shigeaki Suzuki, Emiko Tsuda, Yuriko Nagane, Hiroyuki Murai, Masayuki Masuda, Shingo Konno, Yasushi Suzuki, Shunya Nakane, Kazuo Fujihara, Norihiro Suzuki, Kimiaki Utsugisawa
• Journal: Muscle & nerve (Muscle Nerve) Vol. 51 Issue 5 Pg. 692-6 (May 2015) ISSN: 1097-4598 [Electronic] United States
• PMID: 25155615 (Publication Type: Journal Article, Multicenter Study)
• Copyright: © 2014 Wiley Periodicals, Inc.

Chemical References

• Adrenal Cortex Hormones
• Immunoglobulins, Intravenous
• Prednisolone

Topics

• Administration, Oral
• Adolescent
• Adrenal Cortex Hormones (administration & dosage, therapeutic use)
• Adult
• Aged
• Aged, 80 and over
• Combined Modality Therapy
• Cross-Sectional Studies
• Dose-Response Relationship, Drug
• Female
• Humans
• Immunoglobulins, Intravenous (therapeutic use)
• Japan
• Longitudinal Studies
• Male
• Middle Aged
• Myasthenia Gravis (diagnosis, drug therapy)
• Plasma Exchange
• Prednisolone (administration & dosage, therapeutic use)
• Regression Analysis
• Severity of Illness Index
• Treatment Outcome
• Young Adult